has completed a debt for equity exchange as part of a restructuring transaction

Duff & Phelps Advised the Special Committee of the Board of Directors of Xtant Medical Holdings, Inc. (NYSE American: XTNT) in Its Debt Restructuring Transaction

Contact Us

On August 10, 2020, Xtant Medical Holdings, Inc. (NYSE American: XTNT) ("the Company"), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has entered into a Restructuring and Exchange Agreement with the lenders under its credit facility to restructure Xtant’s outstanding indebtedness, including the exchange of certain indebtedness outstanding under the facility, together with accrued and unpaid interest thereon, into shares of Xtant common stock.

The primary purpose of the restructuring is to improve Xtant’s capital structure by reducing its outstanding debt, which the Company expects will facilitate future access to capital markets for investment in its growth initiatives, and provide a path to possibly regain compliance with the NYSE American continued listing standards.

Duff & Phelps served as a financial advisor to the special committee of the board of directors of Xtant Medical Holdings, Inc.and provided a fairness opinion in connection with the transaction.

About Xtant Medical Holdings, Inc. 
Xtant Medical Holdings, Inc. is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Fox Rothschild LLP served as legal counsel to Xtant Medical Holdings, Inc. and Stoel Rives LLP served as legal counsel to the special committee.

2020-08-12T00:00:00.0000000 /-/media/assets/images/transactions/2020/xtant-medical.jpg /about-us/transactions/fairness-opinions/fairness-opinion-xtant-medical-holdings-inc case study {D59CA77E-C551-45A3-BE89-F567210C5A60} {6B6F3B01-98A6-4BC2-B2CD-CBD127447FB5} {49ED5FA4-1B37-4C7A-8D38-6861240EC2CC} {4DACD310-421A-42AC-BEF4-8AA7E70484CD} {D3AE3EC6-3254-4441-B111-1AF8D558906C} {5CE144D0-ADDC-43A3-95E4-3428CA819BF8} {DF0A8D82-EB98-4261-8951-BF842E034FA8} {B871D4F9-5FCB-40B9-8710-871A30B710AB}

Other Areas We Can Help

Corporate Finance

Corporate Finance

Comprehensive support throughout mergers and acquisitions and other corporate transactions.

Corporate Finance
Corporate Finance

M&A Advisory

Middle-market M&A advisory differentiated by industry expertise and superior deal execution.

M&A Advisory
Transaction Advisory Services

Transaction Advisory Services

Seamless analytical advisory through the deal continuum, from transaction origination to closing.

Transaction Advisory Services

Related Case Studies

Insights

M&A Advisory

China Transactions Insights – Fall 2021

M&A Advisory
Transaction Advisory

Is There an Investment Opportunity for “Bad” ESG Assets?

Transaction Advisory
M&A Advisory

Diagnostic Imaging Equipment Services Update – Summer 2021

M&A Advisory
LIBOR Update

Duff & Phelps LIBOR Transition Advisory Newsletter – August 2021

LIBOR Update

News